About
Jonathan Sporn holds a BS from Duke University and an MD from the University of Miami. He has held leadership roles including Chief of Psychiatry in the Boston area, researcher at Mass General Hospital and the NIH, and clinical positions at Johnson & Johnson and Pfizer in neuroscience and psychiatry. He previously founded Perception Neuroscience, which exited, and is currently an Assistant Professor of Psychiatry and Experimental Therapeutics at Columbia University while founding Gilgamesh Pharmaceuticals.
Founder at Gilgamesh PharmaceuticalsYC S20
Intro paths
YC
Jonathan went through Y Combinator (Summer 2020) — any YC alum in your network can reach them through the YC community.
GP
Their group partner at YC was Jared Friedman, YC Group Partner — the partner who ran Gilgamesh Pharmaceuticals's batch and knows the company first-hand. YC profile ↗
→
In turn, Jonathan can intro founders to Gilgamesh Pharmaceuticals's investors below.
Gilgamesh Pharmaceuticals's investors · 11
Aera VCSingapore · $25K – $5M checksFrontera Technology VenturesTexasFrontier Path VCLondonJames Beshara FundLos AngelesJLSNew YorkMagnetic VenturesBoston · $1M – $6M checksNoeticTorontoPrime Movers LabJackson · $2M – $30M checks · since 2022PsyMed VenturesBerkeleyStrawberry Creek VenturesManchesterY CombinatorSan Francisco · $500K checks · since 2020
Co-founders at Gilgamesh Pharmaceuticals
AK
Andrew KruegelFounder
DS
Dalibor SamesFounder
JS
JONATHAN SPORNFounder
AK
Andrew Kruegel, Ph.D.Executive Officer
JS
Jonathan Sporn, M.D.President and Chief Executive Officer
Founder at Gilgamesh PharmaceuticalsYC S20
Intro paths
YC
Jonathan went through Y Combinator (Summer 2020) — any YC alum in your network can reach them through the YC community.
GP
Their group partner at YC was Jared Friedman, YC Group Partner — the partner who ran Gilgamesh Pharmaceuticals's batch and knows the company first-hand. YC profile ↗
→
In turn, Jonathan can intro founders to Gilgamesh Pharmaceuticals's investors below.
Gilgamesh Pharmaceuticals's investors · 11
Aera VCSingapore · $25K – $5M checksFrontera Technology VenturesTexasFrontier Path VCLondonJames Beshara FundLos AngelesJLSNew YorkMagnetic VenturesBoston · $1M – $6M checksNoeticTorontoPrime Movers LabJackson · $2M – $30M checks · since 2022PsyMed VenturesBerkeleyStrawberry Creek VenturesManchesterY CombinatorSan Francisco · $500K checks · since 2020
Co-founders at Gilgamesh Pharmaceuticals
JS
Jonathan SpornFounder
AK
Andrew KruegelFounder
DS
Dalibor SamesFounder
AK
Andrew Kruegel, Ph.D.Executive Officer
JS
Jonathan Sporn, M.D.President and Chief Executive Officer
Experience
- Gilgamesh PharmaceuticalsChief Executive Officer and Chairman of the Board of Directorscurrent2019 — presentNew York City Metropolitan Area
- Gilgamesh PharmaceuticalsChief Executive Officer and Chairman of the Boardcurrent2019 — presentNYC
- Gilgamesh PharmaceuticalsChief Executive Officer2019New York City Metropolitan Area
- Gilgamesh PharmaceuticalsFounder, CEO, and President2019New York, United States
- Columbia University in the City of New YorkAssistant Professor of Psychiatry and Experimental Therapeuticscurrent2021 — presentNew York, United States
- Gilgamesh Pharmaceuticals IncFounder, CEO and Chairman of the Board of Gilgamesh Pharmaceuticals2019
- Perception Neuroscience Inc.Chief Scientific Officer2018 — 2019NYC
- Perception Neuroscience Inc.Founder, President and CEO2017 — 2018NYC
- PfizerSenior Director2015 — 2017NYC
- PfizerDirector2006 — 2015Greater New York City Area
- JNJDirector Neurology and Psychiatry2003 — 2006
- NIHFellow2000 — 2003
- NIHFellow2000 — 2003
- Massachusetts General HospitalClinical Associate1995 — 2000
Skills & more
Clinical Trials27Pain Management12Drug Development13Clinical Development22Drug Discovery7Neuroscience38Neurology18Pharmaceutical Industry12Lifesciences4Healthcare8Oncology9Clinical Research27
+4 more
PsychiatryBiotechnologyPharmacologyBiomarkers- Board Certified in Psychiatry by American Board of Psychiatry and Neurology — American Board of Psychiatry and Neurology, Inc.
From Jonathan's professional profile.
Frequently asked questions
- Who is Jonathan Sporn?
- Jonathan Sporn holds a BS from Duke University and an MD from the University of Miami. He has held leadership roles including Chief of Psychiatry in the Boston area, researcher at Mass General Hospital and the NIH, and clinical positions at Johnson & Johnson and Pfizer in neuroscience and psychiatry. He previously founded Perception Neuroscience, which exited, and is currently an Assistant Professor of Psychiatry and Experimental Therapeutics at Columbia University while founding Gilgamesh Pharmaceuticals.
- Where does Jonathan Sporn work?
- Jonathan Sporn is Founder of Gilgamesh Pharmaceuticals.
- What companies did Jonathan Sporn found?
- Jonathan Sporn founded Gilgamesh Pharmaceuticals.
- Where did Jonathan Sporn go to school?
- Jonathan Sporn studied at University of Miami Miller School of Medicine (MD, Medicine); Duke University (Bachelor of Science (BS), Zoology/Animal Biology); Y Combinator (S2020, Pharmaceutics and Drug Design).
Founder mafias
Y Combinator mafia8,773
Also came through, then founded or led a company.
Sam AltmanPresidentFounded Tools for Humanity +3Jessica LivingstonCo-founderFounded Y CombinatorAlexis OhanianYC Summer 2005Founded RedditFred EhrsamYC Summer 2012Founded Nudge +1Matt HuangYC Winter 2011Founded HotspotsTrae StephensYC Winter 2022Founded Pursuit +1
+ 8,766 more
Y Combinator mafia4,716
Also came through, then founded or led a company.
Ryan SheaEntrepreneurshipFounded StacksTarek MansourFounded KalshiSuhail DoshiEating beans & riceFounded Playground +1Subomi OluwalanaW22Founded ConvoyDarius "Bubs" MonsefS19Founded Sightbox +3Matthew ScholzFounded Oisin Biotechnologies +3
+ 4,709 more
Duke University mafia127
Also came through, then founded or led a company.
Fred EhrsamB.S.Founded Nudge +1Zach PerretBSFounded PlaidDavid CummingsBSFounded Undaunted +4Romesh SubramanianM.S.Founded RaNA Therapeutics +2Ian PeikonBSEFounded Cajal Therapeutics +1Carmichael RobertsDoctor of Philosophy (PhD) 1995Founded Lyratherapeutics +1
+ 120 more
University of Miami Miller School of Medicine mafia2
Also came through, then founded or led a company.
Same school
Also attended University of Miami Miller School of Medicine6
Beth SeidenbergFounding Managing Director at Westlake Village BioPartnersRichard FryeDirector Of Autism Research, Arkansas Children's Hospital at AIFRasciel SocarrasAdvisory Board Member at HLM Venture PartnersDimi BarotPartner at Wavemaker Three-Sixty HealthNadine HousriFounder/Chief Medical Officer at MednetKaushal Kulkarni, M.D.Founder at Predoc
Also attended Duke University522
Fred EhrsamCo-founder and Senior Advisor at Paradigm; founder of NudgeJeremy LevinePartner at Bessemer Venture PartnersZach PerretCo-founder & CEO of Plaid; co-founder of MischiefJulie YangVice President at InvestcorpScott RaneyManaging Director at Redpoint VenturesJack Bixby LucasGeneral Partner at Lucas Venture Group
+ 516 more
Also attended Y Combinator2,000
Tarek MansourCo-founder & CEO of KalshiSuhail DoshiFounder of Mixpanel; founder of ParticleSubomi OluwalanaCo-founder & CEO of ConvoyMaroof AhmedFounder at Octopus VenturesJustin SwartPartner at Bitkraft Esports VenturesCollin WallaceGeneral Partner at Lobby Capital
+ 1,994 more
Shared employers
Also worked at Gilgamesh Pharmaceuticals6
Also worked at Columbia University in the City of New York174
Reid HoffmanCo-founder of LinkedIn; Partner at GreylockRon ZoriVenture Partner at Lerer HippeauRalph DeBernardoPartner, Investor Relations at Sapphire VenturesRichard ChesworthInvestor at Third Rock VenturesJesse Coors-BlankenshipCo-founder, General Partner at Parkway Venture CapitalLauren YoungHead of Platform at AlleyCorp
+ 168 more
Also worked at Pfizer152
Jigar RaythathaInvestor at Third Rock VenturesAbbie CelnikerInvestor at Third Rock VenturesErin MooreInvestor at Third Rock VenturesJeb KeiperInvestor at Third Rock VenturesRichard ChesworthInvestor at Third Rock VenturesBriggs MorrisonEntrepreneur Partner at MPM BioImpact
+ 146 more
Also worked at JNJ151
Karthik ArdhanareeswaranInvestor at GV (Google Ventures)KobeFinance Director at Hummingbird VenturesMickelFinance & Risk Management at Hummingbird VenturesHal PazInvestor at Khosla VenturesNiall O'DonnellManaging Director at RiverVest Venture PartnersBrad H. ValeFounding General Partner at Treo Ventures, Llc
+ 145 more